Neurocrine Biosciences D
D
NBIX
129.040
USD
-0.38
(-0.29%)
مغلق
حجم التداول
15,230
الربح لكل سهم
5
العائد الربحي
-
P/E
44
حجم السوق
12,770,549,413
الأخبار المقالات
العنوان: Neurocrine Biosciences
القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.